Loading...
Aging Populations And Healthcare Cost Pressures Will Drive Biosimilar Expansion
AnalystHighTarget's Fair Value
US$28.00
71.3% undervalued intrinsic discount05 Sep
US$8.04
1Y
-29.2%7D
-0.1%1Y
-29.2%7D
-0.1%Edit anytime before Aug 27 9:22 PM. Then post Updates to your followers.